Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research> DBS Initiates Coverage on EDGE MEDICAL-B (02675.HK) with Buy, TP HKD68.1
Recommend 3 Positive 2 Negative 0 |
||||
|
||||
|
DBS published a research report initiating coverage on EDGE MEDICAL-B (02675.HK), assigning a Buy rating with a target price of HKD68.1. The broker forecasts a CAGR of 187% in earnings from 2026 to 2028 and a CAGR of 49% in revenue from 2026 to 2030, reaching RMB4.3 billion. It expects the company to achieve breakeven in 2026, driven by the key advantages of its core product MP1000. DBS noted that overseas markets are the main growth driver for EDGE MEDICAL-B, with the company having obtained registration approvals in 55 countries and regions. However, rising global tensions may slow the companys market penetration. (ec/j) This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
